Managed Healthcare Executive February 8, 2024
New research adds to the mounting evidence supporting the safety of Covid-19 mRNA vaccines for pregnant women, with potential benefits for their newborn babies.
The population-based cohort study, published February 6th in JAMA, found that exposure to mRNA COVID-19 vaccination during pregnancy did not increase the risk of adverse events in newborn infants. The study found that babies born to vaccinated mothers were less likely to experience serious complications, including death.
The study involved nearly 200,000 newborns from Sweden and Norway, making it the largest study on this topic to date.
Getting vaccinated can reduce the chances of severe or critical COVID-19 in pregnant individuals. Still, vaccination rates remain lower in pregnant individuals compared to the general population.
“COVID-19 is...
Today's Sponsors
Today's Sponsor